Friday, June 02, 2006

Similarity between Human and Chicken Escherichia coli Isolates in Relation to Ciprofloxacin Resistance Status

Background. The food supply is suspected to be a source of fluoroquinolone-resistant Escherichia coli that cause disease in humans, but supporting molecular data are lacking.

Methods. We performed a molecular-epidemiological comparison, in Barcelona, Spain (1996ndash1998), of 117 contemporaneous, geographically matched E. coli isolates from humans (35 blood isolates and 33 fecal) or chickens (49 fecal) that were either susceptible (n=57) or resistant (n=60) to ciprofloxacin and analyzed them by phylogenetic group, virulence genotype, and O antigens using random amplified polymorphic DNA (RAPD) analysis and pulsed-field gel electrophoresis (PFGE).

Results. When analyzed by phylogenetic distribution, virulence profiles, and O antigens, resistant human isolates were distinct from susceptible human isolates but were largely indistinguishable from chicken isolates, whereas resistant and susceptible chicken isolates were similar. Susceptible human isolates contained more virulence-associated genes and more frequently expressed virulence-associated O antigens than did resistant human or any chicken isolates. Certain resistant human isolates closely resembled chicken isolates by RAPD and PFGE analysis.

Conclusions. Ciprofloxacin-resistant E. coli may arise de novo in poultry from susceptible progenitors, be transmitted to humans via the food supply, and go on to cause potentially life-threatening infections. If confirmed, these findings would mandate efforts to eliminate this reservoir of drug-resistant pathogens and/or to block their transmission to humans.

James R. Johnson, Michael A. Kuskowski, Megan Menard, Abby Gajewski, Mariona Xercavins, and Javier Garau

Wednesday, April 19, 2006

Negligible Risk for Epidemics after Geophysical Disasters

Nathalie Floret,*† Jean-François Viel,*† Frédéric Mauny,*† Bruno Hoen,*† and Renaud Piarroux*†Comments

*University Hospital of Besançon¸ Besançon, France; and †University of Franche-Comté, Besançon, France

Suggested citation for this article


After geophysical disasters (i.e., earthquakes, volcanic eruptions, tsunamis), media reports almost always stress the risk for epidemics; whether this risk is genuine has been debated. We analyzed the medical literature and data from humanitarian agencies and the World Health Organization from 1985 to 2004. Of >600 geophysical disasters recorded, we found only 3 reported outbreaks related to these disasters: 1 of measles after the eruption of Pinatubo in Philippines, 1 of coccidioidomycosis after an earthquake in California, and 1 of Plasmodium vivax malaria in Costa Rica related to an earthquake and heavy rainfall. Even though the humanitarian response may play a role in preventing epidemics, our results lend support to the epidemiologic evidence that short-term risk for epidemics after a geophysical disaster is very low.

Natural disasters are defined as "a disruption of human ecology which exceeds the community's capacity to adjust, so that outside assistance is needed" (1). Their classifications are geophysical (earthquakes, volcanic eruptions, tsunamis), hydrometeorologic (floods and wind storms), and geomorphologic (landslides). When covering these events, media outlets almost always mention the risk for epidemics that could raise the death toll well above an already staggering number of victims. According to the Centers for Disease Control and Prevention (CDC), an epidemic is the occurrence of more cases of disease than expected in a given area or among a specific group of persons over a particular period of time. For many, the word epidemic is associated with large numbers of deaths and poor living conditions, such as those that sometimes occur in refugee camps (2). The term outbreak is synonymous with epidemic and is sometimes preferred because it may not evoke the sensationalism associated with the word epidemic.

In addition to the media, other outlets draw attention to the risk for epidemics. In a letter published 3 weeks after the earthquake in Bam, Iran, in December 2004, the World Health Organization (WHO) warned that potential outbreaks of cholera, typhoid fever, malaria, and leishmaniasis were a major concern (3). WHO also issued a warning about the risk for epidemics that could develop after the 2004 tsunami: "There is an immediate INCREASED RISK of waterborne diseases, i.e., cholera, typhoid fever, shigellosis and hepatitis A and E…. Outbreaks of these diseases could occur at any moment" (4). The high risk for epidemics in areas affected by the tsunami was also pointed out by several papers published during the weeks after the disaster (5,6). Responding to WHO announcements, humanitarian agencies invested effort, time, personnel, and money in gearing up for potential epidemics, and considerable stocks of antimicrobial drugs, rehydration fluids for cholera patients, and vaccines were sent to the field.

However, not all experts support these alarming predictions. Some experts hold that disasters do not usually result in disease outbreaks but may increase disease transmission under certain circumstances (e.g., fecal contamination of water, spread of respiratory diseases in evacuation camps) (7). A similar point of view was published by VanRooyen and Leaning (8) and by de Ville de Goyet (9), who spoke of the myths propagated after disasters, some of which lead to an overestimation of the risk for epidemics.

No article has systematically reviewed published reports dealing with epidemics after geophysical disasters. The role played by outbreaks of infectious diseases in causing illness after geophysical disasters must be identified so that priorities can be defined and resources can be appropriately allocated. A systematic review of medical literature could help answer the question, "Is the risk for epidemics high after a geophysical disaster?" Consequently, we analyzed medical literature of the past 20 years and data provided by several websites and databases that compile outbreak alert messages and situation reports after disasters.

Sunday, April 16, 2006

Vaccines and Preventive Medications for Your Protection: Central Africa

Routine Vaccinations
source http://www.cdc.gov/

Mother and daughter talk with a travel medicine provider before their trip abroad.
Check with your healthcare provider: you and your family may need routine as well as recommended vaccinations.

Before travel, be sure you and your children are up to date on all routine immunizations according to schedules approved by the Advisory Committee on Immunization Practice (ACIP). See the schedule for adults and the schedule for infants and children. Some schedules can be accelerated for travel.

See your doctor at least 4–6 weeks before your trip to allow time for shots to take effect. If it is less than 4 weeks before you leave, you should still see your doctor. It might not be too late to get your shots or medications as well as other information about how to protect yourself from illness and injury while traveling.

Recommended Vaccinations and Preventive Medications

The following vaccines may be recommended for your travel to Central Africa. Discuss your travel plans and personal health with a health-care provider to determine which vaccines you will need.

  • Hepatitis A or immune globulin (IG). Transmission of hepatitis A virus can occur through direct person-to-person contact; through exposure to contaminated water, ice, or shellfish harvested in contaminated water; or from fruits, vegetables, or other foods that are eaten uncooked and that were contaminated during harvesting or subsequent handling.
  • Hepatitis B, especially if you might be exposed to blood or body fluids (for example, health-care workers), have sexual contact with the local population, or be exposed through medical treatment. Hepatitis B vaccine is now recommended for all infants and for children ages 11–12 years who did not receive the series as infants.
  • Malaria: your risk of malaria may be high in all countries in Central Africa, including cities. See your health care provider for a prescription antimalarial drug. For details concerning risk and preventive medications, see Malaria Information for Travelers to Central Africa.
  • Meningococcal (meningitis), if you plan to visit countries in this region that experience epidemics of meningococcal disease during December through June, (see see Map 4-9 on the Meningoccocal Disease page).
  • Rabies, pre-exposure vaccination, if you might have extensive unprotected outdoor exposure in rural areas, such as might occur during camping, hiking, or bicycling, or engaging in certain occupational activities.
  • Typhoid vaccine. Typhoid fever can be contracted through contaminated drinking water or food, or by eating food or drinking beverages that have been handled by a person who is infected. Large outbreaks are most often related to fecal contamination of water supplies or foods sold by street vendors
  • As needed, booster doses for tetanus-diphtheria, measles, and a one-time dose of polio vaccine for adults.
Required Vaccinations